Berning, P.; Hennemann, C.; Tulotta, C.; Schaefer, C.; Lechtape, B.; Hotfilder, M.; El Gourari, Y.; Jürgens, H.; Snaar-Jagalska, E.; Hempel, G.;
et al. The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma. Cancers 2020, 12, 904.
https://doi.org/10.3390/cancers12040904
AMA Style
Berning P, Hennemann C, Tulotta C, Schaefer C, Lechtape B, Hotfilder M, El Gourari Y, Jürgens H, Snaar-Jagalska E, Hempel G,
et al. The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma. Cancers. 2020; 12(4):904.
https://doi.org/10.3390/cancers12040904
Chicago/Turabian Style
Berning, Philipp, Carolin Hennemann, Claudia Tulotta, Christiane Schaefer, Birgit Lechtape, Marc Hotfilder, Yassmine El Gourari, Heribert Jürgens, Ewa Snaar-Jagalska, Georg Hempel,
and et al. 2020. "The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma" Cancers 12, no. 4: 904.
https://doi.org/10.3390/cancers12040904
APA Style
Berning, P., Hennemann, C., Tulotta, C., Schaefer, C., Lechtape, B., Hotfilder, M., El Gourari, Y., Jürgens, H., Snaar-Jagalska, E., Hempel, G., Dirksen, U., & Potratz, J.
(2020). The Receptor Tyrosine Kinase RON and Its Isoforms as Therapeutic Targets in Ewing Sarcoma. Cancers, 12(4), 904.
https://doi.org/10.3390/cancers12040904